2019
DOI: 10.3390/molecules25010052
|View full text |Cite
|
Sign up to set email alerts
|

Specificity Assessment of CRISPR Genome Editing of Oncogenic EGFR Point Mutation with Single-Base Differences

Abstract: In CRISPR genome editing, CRISPR proteins form ribonucleoprotein complexes with guide RNAs to bind and cleave the target DNAs with complete sequence complementarity. CRISPR genome editing has a high potential for use in precision gene therapy for various diseases, including cancer and genetic disorders, which are caused by DNA mutations within the genome. However, several studies have shown that targeting the DNA via sequence complementarity is imperfect and subject to unintended genome editing of other genomi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…The lack of evidence of the direct effect of DNA methylation on gene expression is an important limitation of these studies as the methylation status of a particular CpG site could affect the expression and function of several other DNA elements in addition to the promoter of the closest gene [ 14 ]. The next step in this research field would be a gene-specific modification of the DNA methylation status with a CRISPR/Cas9 related system to validate its effect on gene expression [ 104 , 105 ]. Furthermore, modulation of DNA methylation at specific CpG sites or a single-base mutation within a CpG (associated with a methylation quantitative trait loci) could be performed using this technology to assess the effects on gene expression.…”
Section: Dna Methylationmentioning
confidence: 99%
“…The lack of evidence of the direct effect of DNA methylation on gene expression is an important limitation of these studies as the methylation status of a particular CpG site could affect the expression and function of several other DNA elements in addition to the promoter of the closest gene [ 14 ]. The next step in this research field would be a gene-specific modification of the DNA methylation status with a CRISPR/Cas9 related system to validate its effect on gene expression [ 104 , 105 ]. Furthermore, modulation of DNA methylation at specific CpG sites or a single-base mutation within a CpG (associated with a methylation quantitative trait loci) could be performed using this technology to assess the effects on gene expression.…”
Section: Dna Methylationmentioning
confidence: 99%
“…It is the third generation of enzyme-related gene editing tool, right after zinc-finger nucleases (ZFN) and transcription activator-like effectors nucleases (TALENS) 3 . The CRISPR/Cas9 system was initially discovered as the "immune system" for bacteria and archaea, which uses this strategy to fight against viruses that inject DNA into them [6][7][8][9] . The system has a prominent aspect as it only requires designing a singleguided RNA (sgRNA), which usually consists of twenty base pairs, that is capable of leading the Cas9 enzyme to bind to the site where the DNA sequence needs to be modified [10][11][12][13][14] .…”
Section: Introductionmentioning
confidence: 99%
“…CRISPR-associated protein 9 (CRISPR/Cas9), one of the most widely used genome editing tools, consists of two components: single guide RNA (sgRNA) and Cas9 protein . SgRNA can specifically recognize the target via hybridizing with the target sequence and form dsDNA, which can be recognized and cleaved by Cas9. It should be noted in particular that, with the aid of the nuclease, sgRNA can specifically recognize the target with single-base mismatch within 10 bases close to the PAM. , …”
mentioning
confidence: 99%
“…19−21 It should be noted in particular that, with the aid of the nuclease, sgRNA can specifically recognize the target with single-base mismatch within 10 bases close to the PAM. 22,23 Electrochemical detection platforms have been widely applied in the detection of biomarkers owing to their advantages of low cost and quick speed. The multichannel series piezoelectric quartz crystal (MSPQC) sensor has the characteristics of sensitive, rapid, low-cost, and easy-toimplement point-of-care testing (POCT) detection.…”
mentioning
confidence: 99%